3.1. Primary efficacy assessment
erosion
CHRONIC GASTRITIS, ACUTE AND CHRONIC GASTRITIS, EROSION, ACUTE GASTRITIS
In the FAS analysis, patients in the CKD-495 75 mg group had a higher improvement rate of erosion than those in the AAF 60 mg group. (55.9% vs 39.4%, Improvement rate of erosion in the FAS and PPS analyses (n, %).Results of the Wald test are presented as odds ratio, 95% confidence interval and FAS = full analysis set, PPS = per protocol analysis set.In addition, we performed an analysis of the erosion improvement rate for patients in the FAS with acute or chronic gastritis. Patients in the CKD-495 75 mg group had better improvement of erosion than those in the AAF 60 mg group. In acute gastritis patients, the CKD-495 75 mg group had a numerically higher improvement rate of erosion compared with the AAF 60 mg group (62.1% vs 47.5%, Improvement rate of erosion in acute and chronic gastritis patients (n, %).Results of the Wald test are presented as odds ratio, 95% confidence interval and 